Biovitrum® Prima

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.11.003.Е.009823.12.13
Date of registration and renewal:11.12.2013
Dosage form: & nbspTablets coated with a coating of 1025 mg
Classification "Composition" & nbsp Supplements - vitamins, vitamin-like substances and coenzymes
Classification "Clinical" & nbsp Supplements containing zinc, copper, manganese Supplements containing chromium Supplements containing selenium
Composition: & nbspIngredients: gum arabic, soya powder powder, fenugreek seed powder, barley grass powder, rice husk extract, oat grass powder, calcium carbonate, vitamin C, oregano powder, coriander powder, cinnamon powder, clove powder, peppermint powder coconut powder, ginger root powder, magnesium oxide, vitamin E, turmeric powder, vitamin A, niacin, pantothenic acid, zinc gluconate, vitamin D3, B6, B2, B1, manganese gluconate, copper gluconate, vitamin K1, folic acid, biotin , cyanocobalamin, chromium chloride, n Tria selenite, sodium molybdate.
Scope: & nbspFor realization to the population through the pharmacy network and specialized stores, the departments of the trade network as a biologically active food additive (APPENDIX) - an additional source of vitamins C, E, A, B2, B1, B12, K1, D3, niacin, pantothenic acid, folic acid , biotin and mineral substances (zinc, manganese, copper, chromium, selenium).
Suggested Usage: & nbspAdults take 1 tablet a day with meals, with plenty of water. Duration of admission is 1 month.If necessary, the reception can be repeated.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding, high blood pressure, violation of the rhythm of cardiac activity. Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in a dry place, protected from light and out of reach of children, at a temperature of no higher than 25 ° C.
Research protocols:In exchange for the certificate of state registration No.RU.77.99.11.003.Е.009223.11.13 of 15.11.2013, the expert opinion of the FGBU Research Institute for Nutrition of RAMS №72 / Э-919 / б-13 of 19.09.2013.
Recipient:Unifarm Inc., Representative Office of the Corporation (USA)Unifarm Inc., Representative Office of the Corporation (USA) Russia
Information update date: & nbsp13.05.2016
Instructions
Up